Q4 2024 · 13F-HR
Sio Capital Management, LLCholdings as filed
Filed 2025-02-14 · accession 0001214659-25-002716
$355.4M
Reported value
51
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G4705A100 | ICLR | ICON PLC | $41.0M | 11.5% | 195,500 | Common | SOLE |
| 577933104 | MMS | MAXIMUS INC | $28.5M | 8.01% | 381,423 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $27.1M | 7.61% | 98,003 | Common | SOLE |
| 504922105 | LH | LABCORP HOLDINGS INC | $26.0M | 7.31% | 113,293 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $18.7M | 5.25% | 387,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $18.5M | 5.20% | 174,811 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $16.3M | 4.58% | 451,793 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $13.2M | 3.72% | 2,370,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $12.1M | 3.42% | 2,367,007 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $11.9M | 3.34% | 66,772 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $9.1M | 2.56% | 730,000 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $9.0M | 2.55% | 606,410 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $8.9M | 2.49% | 4,046,797 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $8.8M | 2.49% | 160,051 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $8.8M | 2.47% | 425,574 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $7.7M | 2.18% | 1,054,651 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $7.6M | 2.15% | 11,515,315 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $7.6M | 2.14% | 1,437,500 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $6.8M | 1.92% | 473,292 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $6.7M | 1.90% | 636,300 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $6.2M | 1.75% | 271,687 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $5.4M | 1.53% | 2,054,593 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $5.4M | 1.52% | 3,572,167 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.7M | 1.31% | 73,511 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $4.5M | 1.27% | 504,887 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $4.0M | 1.13% | 907,783 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $3.5M | 0.97% | 121,178 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $3.4M | 0.96% | 1,356,186 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $3.3M | 0.94% | 240,870 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $3.2M | 0.89% | 123,000 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $2.6M | 0.72% | 434,700 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $2.4M | 0.68% | 697,413 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $1.9M | 0.54% | 630,000 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $1.8M | 0.50% | 668,115 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $1.4M | 0.39% | 1,328,352 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.2M | 0.33% | 615,628 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $1.0M | 0.29% | 177,004 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $933,700 | 0.26% | 1,000,000 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $910,024 | 0.26% | 276,603 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $574,292 | 0.16% | 121,672 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $558,000 | 0.16% | 155,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $530,933 | 0.15% | 71,458 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $469,968 | 0.13% | 162,058 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $406,712 | 0.11% | 50,839 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $345,226 | 0.10% | 251,990 | Common | SOLE |
| 590717401 | MESO | MESOBLAST LTD | $229,680 | 0.06% | 11,600 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $100,230 | 0.03% | 130,000 | Common | SOLE |
| 44486Q111 | HUMAW | HUMACYTE INC | $91,746 | 0.03% | 49,998 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $55,400 | 0.02% | 10,000 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $15,440 | 0.00% | 400,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $11,503 | 0.00% | 3,747 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.